C4 Therapeutics, Inc.

C4 Therapeutics, Inc.

CCCC
C4 Therapeutics, Inc.US flagNASDAQ Global Select
3.96
USD
-0.38
- -
328.00MMarket Cap

Income Statement (USD)

APIChat
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Sales/Revenue/Turnover
19
21
33
46
31
21
36
36
+ Sales & Services Revenue
19
21
33
46
31
21
36
36
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
-19
-21
-33
-46
-31
-21
-36
-36
- Operating Expenses
36
57
94
128
161
160
153
140
+ Selling, General & Admin
7
9
15
33
43
42
42
36
+ Research & Development
29
48
78
95
118
118
111
104
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-16
-35
-60
-82
-130
-139
-117
-104
- Non-Operating (Income) Loss
-1
-2
7
2
-1
-8
-12
- -
+ Interest Expense, Net
-1
-2
1
2
-1
-8
-14
-10
+ Interest Expense
- -
- -
1
2
2
1
- -
- -
- Interest Income
1
2
- -
- -
4
10
14
10
+ Other Non-Op (Income) Loss
- -
- -
6
- -
- -
1
2
11
Pretax Income
-16
-33
-67
-84
-128
-131
-105
-105
- Income Tax Expense (Benefit)
- -
1
-1
- -
- -
1
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-16
-34
-66
-84
-128
-132
-105
-105
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-16
-34
-66
-84
-128
-132
-105
-105
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-16
-34
-66
-84
-128
-132
-105
-105
- Preferred Dividends
8
8
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-24
-43
-66
-84
-128
-132
-105
-105
EBIT
-16
-35
-60
-82
-130
-139
-117
-104
EBITDA
-15
-34
-59
-81
-128
-137
-115
-103
EBITDA Margin (%)
-78.06
-158.35
-177.23
-176.13
-411.17
-660.78
-324.19
-285.23
EBITA
-16
-35
-60
-82
-130
-139
-117
-104
Gross Margin (%)
100
100
100
100
100
100
100
100
Operating Margin (%)
-84.64
-165.81
-182.1
-179.39
-416.56
-669.84
-329.3
-290.68
Profit Margin (%)
-81.14
-159.48
-199.83
-183.23
-412.19
-638.34
-295.96
-292.08
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
1
2
2
1
2
2
2
2
Basic Weighted Avg Shares
15
17
11
46
49
50
69
- -
Basic EPS, GAAP
-1.63
-2.47
-5.83
-1.82
-2.62
-2.67
-1.52
- -
Basic EPS from Cont Ops
-1.06
-1.98
-5.83
-1.82
-2.62
-2.67
-1.52
- -
Diluted Weighted Avg Shares
15
17
11
46
49
50
69
- -
Diluted EPS, GAAP
-1.63
-2.47
-5.83
-1.82
-2.62
-2.67
-1.52
- -
Diluted EPS from Cont Ops
-1.06
-1.98
-5.83
-1.82
-2.62
-2.67
-1.52
- -

Balance Sheet (USD)

APIChat
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Total Current Assets
124
97
381
326
288
271
258
258
+ Cash, Cash Equivalents & STI
36
91
372
309
276
254
245
249
+ Cash & Cash Equivalents
36
91
182
76
30
127
55
75
+ ST Investments
- -
- -
190
233
246
127
189
174
+ Accounts & Notes Receiv
86
5
4
6
1
12
3
2
+ Accounts Receivable, Net
86
5
4
6
1
12
3
2
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
1
2
5
11
10
6
10
7
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
23
21
19
181
143
105
92
101
+ Property, Plant & Equip, Net
20
19
17
35
78
71
63
45
+ Property, Plant & Equip
23
23
22
42
86
79
73
56
- Accumulated Depreciation
2
4
6
7
8
8
9
11
+ LT Investments & Receivables
- -
- -
- -
142
61
28
22
49
+ LT Investments
- -
- -
- -
142
61
28
22
49
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
3
3
3
4
5
6
6
7
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
3
3
3
4
5
6
6
7
Total Assets
146
118
400
507
431
376
350
359
+ Payables & Accruals
2
9
11
13
11
13
11
4
+ Accounts Payable
1
5
6
5
1
1
1
1
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
1
3
5
8
10
11
10
3
+ ST Debt
1
1
1
1
7
5
6
6
+ ST Borrowings
- -
- -
- -
- -
2
- -
- -
- -
+ ST Finance Leases
1
1
1
1
5
5
6
6
+ Other ST Liabilities
21
24
32
37
27
25
28
23
+ Deferred Revenue
19
21
28
32
17
15
19
12
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
2
3
4
5
10
9
9
10
Total Current Liabilities
24
34
44
51
45
43
45
33
+ LT Debt
14
13
22
42
80
66
60
54
+ LT Borrowings
- -
- -
10
11
9
- -
- -
- -
+ LT Finance Leases
14
13
12
31
71
66
60
54
+ Other LT Liabilities
189
184
54
24
17
22
28
16
+ Accrued Liabilities
78
73
54
24
17
22
28
16
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
111
111
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
202
197
75
66
97
88
88
69
Total Liabilities
226
230
119
117
142
130
134
102
+ Preferred Equity and Hybrid Capital
111
111
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
4
6
465
658
689
775
850
995
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
4
6
465
658
689
775
850
995
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-83
-117
-184
-268
-396
-528
-634
-739
+ Other Equity
- -
- -
- -
-1
-4
- -
- -
- -
Equity Before Minority Interest
-80
-112
281
390
289
246
216
257
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-80
-112
281
390
289
246
216
257
Total Liabilities & Equity
146
118
400
507
431
376
350
359
Shares Outstanding
41
41
43
49
49
60
71
97
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
14
14
13
32
76
71
66
60
Net Debt
-36
-91
-172
-65
-18
-127
-55
-75
Net Debt to Equity
45.53
80.87
-61.14
-16.77
-6.32
-51.44
-25.7
-29.08
Tangible Common Equity Ratio
-130.21
-188.53
70.17
76.88
67.13
65.38
61.78
71.46
Current Ratio
5.16
2.88
8.69
6.36
6.46
6.34
5.71
7.81
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChat
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
+ Net Income
-16
-34
-66
-84
-128
-132
-105
-105
+ Depreciation & Amortization
1
2
2
1
2
2
2
2
+ Non-Cash Items
3
3
11
26
37
31
31
34
+ Stock-Based Compensation
1
2
3
22
30
27
30
19
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
1
1
1
6
6
6
17
+ Other Non-Cash Adj
2
- -
6
3
1
-3
-5
-3
+ Chg in Non-Cash Work Cap
-6
85
-13
-30
-17
-7
8
-29
+ (Inc) Dec in Accts Receiv
-85
82
- -
-1
4
-10
9
1
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-1
-3
-6
- -
3
-4
1
+ Inc (Dec) in Accts Payable
- -
8
3
3
2
2
-1
-7
+ Inc (Dec) in Other
79
-4
-13
-26
-23
-1
5
-25
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-17
56
-67
-87
-106
-107
-65
-99
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
-3
-1
-1
-1
-5
-2
- -
-1
+ Acq of Fixed Prod Assets
-3
-1
-1
-1
-5
-2
- -
-1
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
340
169
- -
58
44
126
+ Increase in Capital Stock
- -
- -
341
169
- -
58
44
126
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
40
- -
-190
-188
64
160
-51
-8
+ Dec in LT Investment
45
79
104
350
283
290
233
219
+ Inc in LT Investment
-5
-79
-294
-538
-220
-130
-284
-227
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
37
-2
-191
-189
58
158
-51
-9
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
12
- -
- -
-12
- -
- -
+ Cash From Debt
- -
- -
12
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
-12
- -
- -
+ Other Financing Activities
2
- -
-3
2
1
- -
1
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
2
- -
349
171
1
45
45
126
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
22
54
91
-105
-46
97
-71
19
EBITDA
-15
-34
-59
-81
-128
-137
-115
-103
EBITDA Margin (%)
-78.06
-158.35
-177.23
-176.13
-411.17
-660.78
-324.19
-285.23
Free Cash Flow
-20
54
-68
-88
-111
-109
-65
-99
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
46
-167
-88
-111
-121
-65
-99
Free Cash Flow per Basic Share
-1.33
3.15
-5.97
-1.92
-2.28
-2.19
-0.94
- -
Price/Free Cash Flow
- -
- -
-5.66
-17.3
-2.87
-2.67
-3.84
- -
Cash Flow to Net Income
1.08
-1.63
1.01
1.04
0.83
0.81
0.62
0.94
Capital Expenditures
-3
-1
-1
-1
-5
-2
- -
-1